| 标题 |
The results of an open comparative study in parallel groups of the efficacy and safety of the Refnot® (tumor necrosis factor - thymosin - 1 alpha recombinant) drug in the treatment of disseminated triple negative breast cancer |
| 网址 | |
| DOI |
10.29234/2308-9113-2019-7-3-138-149
doi
|
| 其它 |
期刊:Medicina 作者:A.L. Ilyushin; Y.L. Krasnaya; P.I. Shabalkin 出版日期:2019-01-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)